{
    "type": "VariantTherapeuticResponseProposition",
    "predicate": "sensitivity",
    "description": "Treatment of relapsed or refractory acute leukemia with a lysine methyltransferase 2A gene (KMT2A) translocation in adult and pediatric patients 1 year and older",
    "geneContextQualifier": "KMT2A",
    "objectTherapeutic": "Revumenib [Revuforj]"
}